Goldman Sachs Initiates Amsurg At Buy

Goldman Sachs initiated coverage on Amsurg Corp AMSG with a Buy rating. The target price for Amsurg is set to $81. Amsurg shares have gained 35.64 percent over the past 52 weeks, while the S&P 500 index has surged 7.51 percent in the same period. Amsurg shares closed at $68.51 yesterday.